DePuy Synthes Launches TriLEAP™ Lower Extremity Anatomic Plating System

WEST CHESTER, Penn. – August 8, 2024 – Today, Johnson & Johnson MedTech* announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson**, has launched its TriLEAP™ Lower Extremity Anatomic Plating System, a comprehensive system with low-profile, procedure-specific titanium plates, designed for foot and ankle surgeons. The TriLEAP™ System covers a wide range of forefoot and midfoot reconstructive and trauma procedures for the fixation and fusion of bones and bone fragments in adults and adolescents.¹

Foot and ankle plating systems are used in procedures such as bunionectomies, osteotomies, fusions and fractures of the foot or ankle. In the U.S., 16.1% of people suffer from bunions, or hallux valgus, a progressive disorder of the foot in which deformity gradually increases and can eventually compromise desired lifestyle or mobility.²

“With the launch of the TriLEAP™ System, we now have a comprehensive portfolio for first ray surgery, which addresses conditions of the big toe, first toe bone, and foot and ankle reconstruction,” said Oray Boston***, Worldwide President, DePuy Synthes Trauma, Extremities, Craniomaxillofacial, Animal Health and Sports. “This product is key to our strategy, which is to help advance our forefoot and midfoot portfolio to get people back on their feet. It also builds on our established orthopaedics leadership and takes us further in our goal to lead in foot and ankle care.”

The TriLEAP™ System includes contoured and conventional titanium plates that can accommodate multiple screw shaft options to allow for rescue screws. It also features harmonized, color‐coded instrumentation with ergonomic functionality that has ease of use features.¹

“There’s a growing need for plating systems that offer greater precision and customization. Foot and ankle anatomy varies widely among patients, and having plates that can adapt more precisely to individual anatomy can lead to better outcomes,” said Dr. Michael Campbell, M.D., FAAOS, board certified orthopaedic surgeon with Atlantic Orthopaedic Specialists who specializes in conditions of the foot and ankle.^† “I’m excited that the TriLEAP™ System is now available for first ray surgery and foot and ankle reconstruction. The complete and specific set of tools for different procedures means we have a system that truly meets the diverse demands of the operating room, helping us provide even better care for our patients.”¹

The TriLEAP™ System will be featured at the American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting in September. For more information on the system and other DePuy Synthes Foot & Ankle specialty products, read more here.

About DePuy Synthes
DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to healthcare systems worldwide. Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit http://www.depuysynthes.com/.

About Johnson & Johnson MedTech
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized. For more information, visit https://thenext.jnjmedtech.com/.

Cautions Concerning Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding the TriLEAP™ Lower Extremity Anatomic Plating System. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of DePuy Synthes, Inc., Medical Device Business Services, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, including in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in Johnson & Johnson’s subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. None of either DePuy Synthes, Inc., Medical Device Business Services, Inc. nor Johnson & Johnson undertakes to update any forward-looking statement as a result of new information or future events or developments.

###

*Comprising the surgery, orthopaedics, vision, and interventional solutions businesses within Johnson & Johnson’s MedTech segment.

**DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.

***Oray Boston is an employee of Medical Device Business Services, Inc.

† Michael Campbell, M.D., FAAOS is a paid consultant for DePuy Synthes.

Important Information: Prior to use, refer to the instructions for use supplied with the device(s) or indications, contraindications, warnings and precautions.

© DePuy Synthes 2024. All rights reserved. US_DPS_FTAK_387903

Footnotes
¹ CrossRoads TriLEAP™ System Features 03_21_2023 CRE BOX DCO# 1539 Ref# EM23-0008 Rev A

² Cai Y. Song Y. He. Mincong. He W. Zhong X. Wen H. Wei Q. Global prevalence and incidence of hallux valgus: a systematic review and meta-analysis. J Foot Ankle Res. 2023. 10.1186/s13047-023-00661-9